What are the recommended antibiotic treatments and dosing for acute bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotic Treatment for Acute Bacterial Sinusitis

Amoxicillin with or without clavulanate is the first-line antibiotic for acute bacterial sinusitis in adults, dosed at 500-875 mg twice daily (or 500 mg three times daily) for 5-10 days. 1, 2, 3

When to Start Antibiotics

Not all sinusitis requires antibiotics. Diagnose acute bacterial rhinosinusitis (ABRS) when patients present with one of three patterns:

  • Persistent symptoms: Nasal discharge or daytime cough lasting >10 days without improvement
  • Severe onset: Fever ≥102.2°F (39°C) with purulent nasal discharge for ≥3 consecutive days
  • Worsening course: Initial improvement followed by worsening symptoms 4, 5, 2

Watchful waiting without antibiotics is appropriate for uncomplicated ABRS if you can ensure follow-up within 7 days. Start antibiotics only if symptoms fail to improve by day 7 or worsen at any time. 1, 2

First-Line Antibiotic Regimens

Standard Dosing (Most Adults)

Amoxicillin alone:

  • 500 mg three times daily, OR
  • 875 mg twice daily
  • Duration: 5-10 days 6, 1, 2

Amoxicillin-clavulanate (preferred when resistance suspected):

  • 875 mg-125 mg twice daily
  • Duration: 5-10 days 1, 2

The 2026 JAMA study found no difference in treatment failure between amoxicillin-clavulanate and amoxicillin alone (3.0% vs 3.1%), but amoxicillin-clavulanate had higher rates of yeast infections (1.1% vs 0.8%) and C. difficile infections (0.04% vs 0.02%). 3 This supports using amoxicillin alone as the preferred first-line agent unless resistance is a concern.

High-Dose Regimens (When Resistance Suspected)

Use high-dose therapy if the patient:

  • Attended daycare recently (children)
  • Used antibiotics in past 4-6 weeks
  • Lives in areas with >10% penicillin-resistant S. pneumoniae
  • Has moderate-to-severe disease 6, 5

High-dose amoxicillin-clavulanate:

  • Adults: 2000 mg (amoxicillin component) every 12 hours (not exceeding 2 g per dose) 6
  • Children: 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses 5, 7

Penicillin Allergy Alternatives

For non-severe penicillin allergy:

  • Cefuroxime axetil, cefpodoxime proxetil, or cefdinir 6, 8
  • Recent evidence shows cross-reactivity risk with 2nd/3rd generation cephalosporins is negligible 5

For severe (Type 1) penicillin allergy:

  • Levofloxacin or moxifloxacin (respiratory fluoroquinolones) 6, 7
  • Avoid trimethoprim-sulfamethoxazole and azithromycin due to high resistance rates in S. pneumoniae and H. influenzae 4, 9

Treatment Failure Management

If no improvement after 3-5 days or worsening at any time, reassess the diagnosis and switch antibiotics: 6, 1

Second-line options:

  • High-dose amoxicillin-clavulanate (if not used initially)
  • Cefuroxime, cefpodoxime, or cefdinir
  • Respiratory fluoroquinolones (levofloxacin, moxifloxacin) 6, 7

For persistent failure after 21-28 days:

  • Consider anaerobic coverage: add clindamycin or metronidazole to broad-spectrum agent
  • Obtain CT imaging
  • Refer to otolaryngology or allergy/immunology 6

Special Situations

Frontal, ethmoidal, or sphenoidal sinusitis:

  • More serious; consider starting with respiratory fluoroquinolones (levofloxacin, moxifloxacin) or high-dose amoxicillin-clavulanate 7

Severe/toxic appearance:

  • IV ceftriaxone 50 mg/kg (up to 2 g) once daily, then switch to oral after clinical improvement 4, 5

Chronic rhinosinusitis:

  • Do not use empiric antibiotics solely to satisfy third-party requirements for surgery or imaging 2
  • Antibiotics have limited role; focus on intranasal corticosteroids and addressing underlying inflammation 6, 10

Adjunctive Therapies

  • Intranasal corticosteroids: Beneficial as monotherapy for mild-moderate cases or as adjunct to antibiotics 6, 11
  • Nasal saline irrigation: Recommended; safe and effective 9, 11
  • Oral decongestants: May provide symptomatic relief but limited evidence 6
  • Avoid topical decongestants >3 days (risk of rebound congestion) 9

Common Pitfalls

  • Over-diagnosing bacterial sinusitis: Most cases are viral and resolve without antibiotics. Wait 10 days before diagnosing ABRS unless severe symptoms present. 6, 2
  • Using broad-spectrum antibiotics first-line: This drives resistance. Start narrow (amoxicillin) and escalate only if needed. 1, 3
  • Treating chronic rhinosinusitis like acute: Chronic disease requires different management focused on inflammation, not routine antibiotics. 2, 10
  • Ignoring treatment failure: If no improvement by day 7, don't continue the same antibiotic—reassess and change therapy. 6, 1

References

Guideline

clinical practice guideline (update): adult sinusitis executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Guideline

clinical practice guideline: adult sinusitis update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025

Guideline

the diagnosis and management of sinusitis: a practice parameter update.

Journal of Allergy and Clinical Immunology, 2005

Research

Guidelines on the treatment of ABRS in adults.

International journal of clinical practice, 2007

Research

Canadian guidelines for acute bacterial rhinosinusitis: clinical summary.

Canadian family physician Medecin de famille canadien, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.